Moreover, anti-EGFR nanobody–drug conjugates possessing two tandemly fused nanobodies (7D12 and 9G8) with MMAE exhibited potent anti-cancer activity in vivo in a solid tumor mouse model [104]. The gene discussed is EGFR; the disease is cancer.